Effect of Nigella Sativa Oil on Oxidative Stress, Inflammatory, and Glycemic Control Indices in Diabetic Hemodialysis Patients: A Randomized Double-Blind, Controlled Trial
Table 2
Serum concentrations of oxidative stress markers, hs-CRP, and glycemic indices of the patients.
Variables
Nigella sativa group (N = 20)
Placebo group (N = 21)
MD
P
SOD (U/mL)
Baseline
185.60 (4.50)
192.69 (4.75)
−7.09
.287b
End
203.48 (3.24)
198.03 (4.48)
5.44
.064c, .040d
MD (95% CI)
−17.88 (−26.87, −8.89)
-5.34 (-13.03, 2.33)
Pa
.001
.162
TAC (mmol/L)
Baseline
1.34 (.01)
1.36 (.01)
−.01
.331b
End
1.40 (.01)
1.35 (.01)
.05
<.001c, <.001d
MD (95% CI)
−.06 (−.08, −.04)
.01 (−.01, .03)
Pa
<.001
.353
MDA (μmol/L)
Baseline
2.19 (.07)
1.91 (.06)
.27
.007b
End
1.86 (.05)
1.89 (.05)
−.02
.022c, .025d
MD (95% CI)
.32 (.23, .42)
.01 (-.11, .15)
Pa
<.001
.782
Hs-CRP (mg/L)
Baseline
8.59 (.40)
9.01 (.59)
−42
.560b
End
7.55 (.38)
8.86 (.57)
−1.30
.022c, .017d
MD (95% CI)
1.04 (.63, 1.44)
.15 (-.62, .93)
Pa
<.001
.680
FBS (mg/dL)
Baseline
190.70 (6.08)
156.57 (3.43)
3.24
.510b
End
149.91 (2.68)
152.85 (3.10)
−2.93
.004c, .027d
MD (95% CI)
−16.38 (−25.04, −7.72)
−1.99 (−13.68, 9.70)
Pa
.001
.726
INS (μIU/mL)
Baseline
15.91 (2.07)
19.39 (2.49)
-3.47
.294b
End
19.66 (1.98)
20.00 (2.28)
-.34
.459c, .558d
MD (95% CI)
3.74 (1.10, 6,38)
.60 (−4.13, 5.35)
Pa
.008
.791
HbA1c (%)
Baseline
8.26 (.33)
8.38 (.37)
−11
.815b
End
7.76 (.23)
8.32 (.31)
−55
.009c, .014d
MD (95% CI)
−.49(−90, −09)
−.06 (−.29, .17)
Pa
.019
.572
Mean (SD) and mean differences (95% CI) are presented for normally distrusted data; median (IQB) and median differences are presented for data not normally distributed. SOD = superoxide dismutase; MDA = malondialdehyde; TAC = total antioxidant capacity; hs-CRP = high-sensitivity C-reactive protein; FBS = fasting blood sugar; INS = insulin; MD = mean difference; SD = standard deviation; IQR = interquartile range; ANCOVA = analysis of covariance. Pa = paired samples t-test, Pb = independent samples t-test, Pc = ANCOVA test, adjusted for baseline values (Model 1), and Pd = ANCOVA test, adjusted for baseline values, energy intake1, and BMI (Model 2).